PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
Federal · 119th Congress

HR7237 Chemical Abortion Risk Awareness Act

Direction

Abortion medication abortionAI label

Restricts abortion access model confidence 90%

Imposes detailed informed-consent requirements specific to chemical (medication) abortion, including providing and reading FDA label warnings 24 hours in advance, with penalties for noncompliance, so less medication-abortion access.

A chemical abortion shall not knowingly be performed or induced, or be attempted to be performed or induced, by a chemical abortion provider referred to in subsection (a) unless the chemical abortion provider, not later than 24 hours before the chemical abortion-- (1) provides to the woman, in both electronic and paper form, a full Food and Drug Administration-approved product label for each abortion-inducing drug to be used, with the `Warnings and Precautions' and `Adverse Reactions' sections of the label (or such other similar sections) highlighted;

✓ Quote verified word for word in the bill text

Abortion provider clinic regulationAI label

Restricts abortion access model confidence 85%

Requires chemical-abortion providers receiving federal funds to submit an implementation plan, comply with specific informed-consent rules, and face withholding of federal funding plus a private right of action for violations, so more regulation of abortion providers.

any chemical abortion provider receiving Federal funds, or working in, for, or on behalf of a medical practice or company that receives Federal funds, who knowingly performs or induces, or attempts to perform or induce, any chemical abortion, shall comply with the requirements of this title.

✓ Quote verified word for word in the bill text

Abortion funding insuranceAI label

Restricts abortion access model confidence 80%

Authorizes withholding of federal funding from noncompliant chemical-abortion providers or their employers, so less public funding for medication abortion.

in the case that a chemical abortion provider is not in compliance with the requirements of this title, the Secretary may withhold the Federal funding of the chemical abortion provider, the entity at which the chemical abortion provider is employed or on behalf of which the chemical abortion provider performs or induces chemical abortions, or both.

✓ Quote verified word for word in the bill text

  1. Introduced (completed)
  2. Committee
  3. Passed one chamber
  4. Passed both
  5. President
  6. Law

Stage: Committee · step 2 of 6

Last action
2026-01-23: Referred to the House Committee on Energy and Commerce.
Filed
2026-01-23
Committee
Energy and Commerce Committee
Sponsor
Marlin A. Stutzman R + 2 cosponsors (2 R)

Why the model tagged it this way: The bill adds a new title to the Public Health Service Act that specifically regulates chemical (medication) abortions by mandating detailed informed-consent procedures using FDA labels, requiring implementation plans, authorizing withholding of federal funds for noncompliance, creating a private right of action with damages, and including a savings clause for stricter state laws. These provisions substantively address medication abortion, provider regulation, and funding; no other listed topics are substantively addressed.

Related bills

Sponsors

Text versions

History (3 actions)
DateChamberAction
2026-01-23LibraIntroduced in House
2026-01-23LibraIntroduced in House
2026-01-23HouseReferred to the House Committee on Energy and Commerce.